2023 Form 5500 filing — Ascent Pharmaceuticals Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011135457NAL0037123904001) for Ascent Pharmaceuticals Inc. 401(K) Plan, reported by Ascent Pharmaceuticals Inc. under EIN 45-3542806 and plan number 001. It reports 415 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).
- EFAST2 acknowledgement
- 20241011135457NAL0037123904001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Ascent Pharmaceuticals Inc.
- EIN
- 45-3542806
- Plan number
- 001
- Location
- Central Islip, NY
- Participants
- 415
- Schedules available
- Schedule H
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $7,847,173
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $7,847,173
- Employer contributions
- $653,627
- Participant contributions
- $947,042
- Total income / additions
- $2,657,747
- Benefits paid
- $379,791
- Administrative expenses
- $7,353
- Total expenses
- $387,144
- Net increase / (decrease)
- $2,270,603
- Schedule source
- Schedule H